ArticleVeterinary research communications2025
Innovative essential oil formulations for in vitro inhibition of Biofilm-Forming Extended-Spectrum β-Lactamase-Producing Escherichia coli isolated from canine infectious diarrhea.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chemical Composition and Synergistic Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of bacteria producing extended-spectrum β-lactamases (ESBLs) has presented a substantial challenge to veterinary and human medicine. ESBL-producing Escherichia coli exhibits biofilm-forming capabilities that enhance its persistence in domestic animals, contribute to chronic infectious diarrhea, and increase the risk of treatment failure. This study investigated ESBL-producing E. coli in dogs and evaluated the antimicrobial and antibiofilm activities of NHK-EO, an innovative essential oil formulation derived from Coleus amboinicus (N), Ocimum basilicum (H), and Ocimum tenuiflorum (K).
methodsThe chemical composition of NHK-EO was analyzed using gas chromatography-mass spectrometry (GC-MS). Fifty-six rectal swab samples were randomly collected from dogs aged 3 months to 10 years, including 30 clinically healthy and 26 diarrheic animals of both sexes. Bacterial isolation and identification were conducted using conventional biochemical tests and the VITEK automated system. ESBL production was confirmed through genotypic detection of bla
resultsGC-MS analysis of NHK-EO revealed three major constituents: carvacrol (16.37%), eugenol (15.04%), and linalool (13.97%). In total, 78 Gram-negative bacterial isolates were identified, with E. coli being the predominant species (56 isolates, 71.79%). Among these, four bla
conclusionsNHK-EO possesses significant antimicrobial and antibiofilm activities against E. coli, including ESBL-producing strains, indicating its potential as an alternative therapeutic agent to mitigate antimicrobial resistance. Further research is warranted to explore its clinical applications in veterinary and human medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.